PubRank

C J Refino

Author PubWeight™ 12.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci U S A 1994 1.52
2 A slow clearing, fibrin-specific, PAI-1 resistant variant of t-PA (T103N, KHRR 296-299 AAAA). Thromb Haemost 1993 1.20
3 The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator. Thromb Haemost 1988 0.97
4 New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. Circulation 1995 0.93
5 D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Thromb Haemost 1986 0.84
6 Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines. J Med Chem 1996 0.84
7 Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. J Pharmacol Exp Ther 1993 0.83
8 A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding. Stroke 1994 0.82
9 Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat. Am J Physiol 1984 0.82
10 Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig. Thromb Haemost 2001 0.81
11 A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent. Blood 1997 0.81
12 Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator. Protein Eng 1992 0.78
13 Red cell superoxide dismutase is increased in iron deficiency anemia. Acta Haematol 1985 0.78
14 Rate of repair of iron deficiency anemia and blood loss anemia in young and mature rats. Am J Clin Nutr 1983 0.77
15 Work performance in iron deficiency of increasing severity. J Appl Physiol (1985) 1985 0.75
16 An experimental model of intracranial hemorrhage during thrombolytic therapy with t-PA. Thromb Haemost 1996 0.75
17 Limiting systemic plasminogenolysis reduces the bleeding potential for tissue-type plasminogen activators but not for streptokinase. Thromb Haemost 1996 0.75
18 Erythropoietin concentration during the development and recovery from iron deficiency in the rat. Blood 1985 0.75